nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—SLC16A1—Methotrexate—germ cell cancer	0.143	0.172	CbGbCtD
Nateglinide—PTGS1—Ifosfamide—germ cell cancer	0.108	0.13	CbGbCtD
Nateglinide—CYP3A7—Ifosfamide—germ cell cancer	0.0867	0.104	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0867	0.104	CbGbCtD
Nateglinide—ABCC4—Methotrexate—germ cell cancer	0.0689	0.0826	CbGbCtD
Nateglinide—CYP3A5—Ifosfamide—germ cell cancer	0.065	0.0779	CbGbCtD
Nateglinide—PTGS1—Etoposide—germ cell cancer	0.0518	0.0621	CbGbCtD
Nateglinide—CYP2C9—Ifosfamide—germ cell cancer	0.0436	0.0523	CbGbCtD
Nateglinide—CYP3A5—Etoposide—germ cell cancer	0.0311	0.0372	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—germ cell cancer	0.03	0.0359	CbGbCtD
Nateglinide—ALB—Methotrexate—germ cell cancer	0.0256	0.0306	CbGbCtD
Nateglinide—CYP3A4—Ifosfamide—germ cell cancer	0.0254	0.0304	CbGbCtD
Nateglinide—CYP2C9—Cisplatin—germ cell cancer	0.0212	0.0254	CbGbCtD
Nateglinide—CYP2D6—Vinblastine—germ cell cancer	0.0212	0.0254	CbGbCtD
Nateglinide—CYP3A4—Vinblastine—germ cell cancer	0.0135	0.0161	CbGbCtD
Nateglinide—CYP3A4—Etoposide—germ cell cancer	0.0121	0.0145	CbGbCtD
Nateglinide—SLC15A2—choroid plexus—germ cell cancer	0.0099	0.0931	CbGeAlD
Nateglinide—CYP2C9—cardial valve—germ cell cancer	0.00919	0.0864	CbGeAlD
Nateglinide—PPARG—dermis—germ cell cancer	0.00651	0.0613	CbGeAlD
Nateglinide—PPARG—Teniposide—Etoposide—germ cell cancer	0.00411	1	CbGdCrCtD
Nateglinide—PPARG—appendage—germ cell cancer	0.00329	0.031	CbGeAlD
Nateglinide—Trauma—Bleomycin—germ cell cancer	0.00268	0.0625	CcSEcCtD
Nateglinide—PPARG—endothelium—germ cell cancer	0.00199	0.0187	CbGeAlD
Nateglinide—CYP2C9—urine—germ cell cancer	0.00198	0.0186	CbGeAlD
Nateglinide—PPARG—blood vessel—germ cell cancer	0.00183	0.0172	CbGeAlD
Nateglinide—Amphetamine—SLC22A3—germ cell cancer	0.0017	0.519	CrCbGaD
Nateglinide—Methamphetamine—SLC22A3—germ cell cancer	0.00157	0.481	CrCbGaD
Nateglinide—CYP3A4—urine—germ cell cancer	0.00151	0.0142	CbGeAlD
Nateglinide—CYP2D6—urine—germ cell cancer	0.00149	0.014	CbGeAlD
Nateglinide—ABCC8—brainstem—germ cell cancer	0.00131	0.0123	CbGeAlD
Nateglinide—PPARG—neck—germ cell cancer	0.00131	0.0123	CbGeAlD
Nateglinide—PTGS1—ganglion—germ cell cancer	0.00123	0.0116	CbGeAlD
Nateglinide—ABCC8—telencephalon—germ cell cancer	0.00117	0.011	CbGeAlD
Nateglinide—SLC16A1—eye—germ cell cancer	0.00116	0.0109	CbGeAlD
Nateglinide—SLC16A1—retina—germ cell cancer	0.00115	0.0108	CbGeAlD
Nateglinide—UGT1A9—endocrine gland—germ cell cancer	0.00114	0.0107	CbGeAlD
Nateglinide—PPARG—embryo—germ cell cancer	0.00109	0.0103	CbGeAlD
Nateglinide—PTGS1—endothelium—germ cell cancer	0.00106	0.01	CbGeAlD
Nateglinide—SLC16A1—telencephalon—germ cell cancer	0.00106	0.00997	CbGeAlD
Nateglinide—Injury—Bleomycin—germ cell cancer	0.00101	0.0235	CcSEcCtD
Nateglinide—SLC16A1—decidua—germ cell cancer	0.001	0.00945	CbGeAlD
Nateglinide—Urine output increased—Ifosfamide—germ cell cancer	0.000987	0.023	CcSEcCtD
Nateglinide—PTGS1—blood vessel—germ cell cancer	0.00098	0.00922	CbGeAlD
Nateglinide—ABCC8—pituitary gland—germ cell cancer	0.000949	0.00892	CbGeAlD
Nateglinide—CYP3A7—endocrine gland—germ cell cancer	0.000949	0.00892	CbGeAlD
Nateglinide—KCNJ11—adrenal gland—germ cell cancer	0.00092	0.00865	CbGeAlD
Nateglinide—ABCC8—medulla oblongata—germ cell cancer	0.000916	0.00861	CbGeAlD
Nateglinide—Polyuria—Ifosfamide—germ cell cancer	0.000902	0.021	CcSEcCtD
Nateglinide—SLC16A1—gonad—germ cell cancer	0.000885	0.00832	CbGeAlD
Nateglinide—SLC16A1—uterus—germ cell cancer	0.000879	0.00827	CbGeAlD
Nateglinide—SLC16A1—pituitary gland—germ cell cancer	0.000863	0.00812	CbGeAlD
Nateglinide—KCNJ11—female gonad—germ cell cancer	0.000858	0.00807	CbGeAlD
Nateglinide—PPARG—skin of body—germ cell cancer	0.000849	0.00798	CbGeAlD
Nateglinide—ABCC8—adrenal gland—germ cell cancer	0.000848	0.00797	CbGeAlD
Nateglinide—PPARG—decidua—germ cell cancer	0.000843	0.00793	CbGeAlD
Nateglinide—ABCC8—midbrain—germ cell cancer	0.000837	0.00787	CbGeAlD
Nateglinide—SLC16A1—medulla oblongata—germ cell cancer	0.000833	0.00783	CbGeAlD
Nateglinide—Neuropathy peripheral—Vinblastine—germ cell cancer	0.000829	0.0193	CcSEcCtD
Nateglinide—ABCC8—spinal cord—germ cell cancer	0.000817	0.00768	CbGeAlD
Nateglinide—KCNJ11—endocrine gland—germ cell cancer	0.000798	0.0075	CbGeAlD
Nateglinide—Osteoarthritis—Ifosfamide—germ cell cancer	0.000792	0.0185	CcSEcCtD
Nateglinide—KCNJ11—head—germ cell cancer	0.000788	0.00741	CbGeAlD
Nateglinide—Polyuria—Cisplatin—germ cell cancer	0.000778	0.0181	CcSEcCtD
Nateglinide—SLC16A1—adrenal gland—germ cell cancer	0.000771	0.00725	CbGeAlD
Nateglinide—SLC16A1—midbrain—germ cell cancer	0.000761	0.00716	CbGeAlD
Nateglinide—SLC15A2—retina—germ cell cancer	0.000757	0.00712	CbGeAlD
Nateglinide—SLC16A1—spinal cord—germ cell cancer	0.000743	0.00699	CbGeAlD
Nateglinide—PPARG—uterus—germ cell cancer	0.000738	0.00694	CbGeAlD
Nateglinide—ABCC8—endocrine gland—germ cell cancer	0.000735	0.00691	CbGeAlD
Nateglinide—ABCC8—head—germ cell cancer	0.000726	0.00682	CbGeAlD
Nateglinide—SLC16A1—female gonad—germ cell cancer	0.000719	0.00676	CbGeAlD
Nateglinide—KCNJ11—cerebellum—germ cell cancer	0.000703	0.00661	CbGeAlD
Nateglinide—SLC15A1—endocrine gland—germ cell cancer	0.000703	0.00661	CbGeAlD
Nateglinide—ABCC8—testis—germ cell cancer	0.000701	0.00659	CbGeAlD
Nateglinide—SLC15A2—telencephalon—germ cell cancer	0.000696	0.00655	CbGeAlD
Nateglinide—ABCC4—uterus—germ cell cancer	0.00067	0.0063	CbGeAlD
Nateglinide—ORM1—bone marrow—germ cell cancer	0.00067	0.0063	CbGeAlD
Nateglinide—SLC16A1—endocrine gland—germ cell cancer	0.000669	0.00629	CbGeAlD
Nateglinide—ORM1—spinal cord—germ cell cancer	0.000667	0.00627	CbGeAlD
Nateglinide—SLC16A1—head—germ cell cancer	0.00066	0.00621	CbGeAlD
Nateglinide—ABCC8—cerebellum—germ cell cancer	0.000647	0.00609	CbGeAlD
Nateglinide—PPARG—adrenal gland—germ cell cancer	0.000647	0.00608	CbGeAlD
Nateglinide—SLC16A1—testis—germ cell cancer	0.000638	0.006	CbGeAlD
Nateglinide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000627	0.0707	CbGpPWpGaD
Nateglinide—PPARG—bone marrow—germ cell cancer	0.000626	0.00589	CbGeAlD
Nateglinide—ALB—adrenal gland—germ cell cancer	0.000607	0.00571	CbGeAlD
Nateglinide—SLC22A6—brain—germ cell cancer	0.000604	0.00568	CbGeAlD
Nateglinide—PPARG—female gonad—germ cell cancer	0.000603	0.00567	CbGeAlD
Nateglinide—ORM1—endocrine gland—germ cell cancer	0.0006	0.00564	CbGeAlD
Nateglinide—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000598	0.0139	CcSEcCtD
Nateglinide—SLC16A1—cerebellum—germ cell cancer	0.000589	0.00554	CbGeAlD
Nateglinide—ABCC4—adrenal gland—germ cell cancer	0.000588	0.00553	CbGeAlD
Nateglinide—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000577	0.0134	CcSEcCtD
Nateglinide—Sweating increased—Cisplatin—germ cell cancer	0.000575	0.0134	CcSEcCtD
Nateglinide—KCNJ11—brain—germ cell cancer	0.000571	0.00537	CbGeAlD
Nateglinide—ABCC4—bone marrow—germ cell cancer	0.000568	0.00535	CbGeAlD
Nateglinide—SLC15A2—pituitary gland—germ cell cancer	0.000567	0.00533	CbGeAlD
Nateglinide—Erythema multiforme—Dactinomycin—germ cell cancer	0.000565	0.0132	CcSEcCtD
Nateglinide—PPARG—endocrine gland—germ cell cancer	0.000561	0.00528	CbGeAlD
Nateglinide—PPARG—head—germ cell cancer	0.000554	0.00521	CbGeAlD
Nateglinide—KCNJ11—lymph node—germ cell cancer	0.000552	0.00519	CbGeAlD
Nateglinide—ABCC4—female gonad—germ cell cancer	0.000548	0.00515	CbGeAlD
Nateglinide—SLC15A2—medulla oblongata—germ cell cancer	0.000547	0.00515	CbGeAlD
Nateglinide—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.000546	0.0127	CcSEcCtD
Nateglinide—PPARG—testis—germ cell cancer	0.000535	0.00503	CbGeAlD
Nateglinide—PPARG—Nuclear Receptors—NR0B1—germ cell cancer	0.000527	0.0594	CbGpPWpGaD
Nateglinide—Sweating increased—Etoposide—germ cell cancer	0.000527	0.0123	CcSEcCtD
Nateglinide—ABCC8—brain—germ cell cancer	0.000526	0.00495	CbGeAlD
Nateglinide—Erythema multiforme—Ifosfamide—germ cell cancer	0.000518	0.0121	CcSEcCtD
Nateglinide—Neuropathy peripheral—Cisplatin—germ cell cancer	0.000516	0.012	CcSEcCtD
Nateglinide—ABCC4—endocrine gland—germ cell cancer	0.00051	0.00479	CbGeAlD
Nateglinide—SLC15A2—adrenal gland—germ cell cancer	0.000507	0.00476	CbGeAlD
Nateglinide—ABCC4—head—germ cell cancer	0.000503	0.00473	CbGeAlD
Nateglinide—ALB—testis—germ cell cancer	0.000502	0.00472	CbGeAlD
Nateglinide—SLC15A2—midbrain—germ cell cancer	0.0005	0.0047	CbGeAlD
Nateglinide—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000498	0.0116	CcSEcCtD
Nateglinide—Immune system disorder—Ifosfamide—germ cell cancer	0.000495	0.0115	CcSEcCtD
Nateglinide—SLC15A2—spinal cord—germ cell cancer	0.000488	0.00459	CbGeAlD
Nateglinide—Cough—Bleomycin—germ cell cancer	0.000487	0.0113	CcSEcCtD
Nateglinide—ABCC4—testis—germ cell cancer	0.000486	0.00457	CbGeAlD
Nateglinide—SLC16A1—Pyruvate metabolism—CRABP1—germ cell cancer	0.000482	0.0543	CbGpPWpGaD
Nateglinide—SLC16A1—brain—germ cell cancer	0.000478	0.0045	CbGeAlD
Nateglinide—Malnutrition—Ifosfamide—germ cell cancer	0.000477	0.0111	CcSEcCtD
Nateglinide—PTGS1—telencephalon—germ cell cancer	0.000476	0.00447	CbGeAlD
Nateglinide—Neuropathy peripheral—Etoposide—germ cell cancer	0.000473	0.011	CcSEcCtD
Nateglinide—SLC15A2—female gonad—germ cell cancer	0.000472	0.00444	CbGeAlD
Nateglinide—Jaundice—Etoposide—germ cell cancer	0.00047	0.0109	CcSEcCtD
Nateglinide—Urine output increased—Methotrexate—germ cell cancer	0.000467	0.0109	CcSEcCtD
Nateglinide—SLC16A1—lymph node—germ cell cancer	0.000462	0.00435	CbGeAlD
Nateglinide—Hepatobiliary disease—Etoposide—germ cell cancer	0.000456	0.0106	CcSEcCtD
Nateglinide—PTGS1—skin of body—germ cell cancer	0.000454	0.00427	CbGeAlD
Nateglinide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000441	0.0103	CcSEcCtD
Nateglinide—CYP2D6—brainstem—germ cell cancer	0.00044	0.00414	CbGeAlD
Nateglinide—SLC15A2—endocrine gland—germ cell cancer	0.000439	0.00413	CbGeAlD
Nateglinide—SLC15A2—head—germ cell cancer	0.000434	0.00408	CbGeAlD
Nateglinide—Polyuria—Methotrexate—germ cell cancer	0.000427	0.00994	CcSEcCtD
Nateglinide—Immune system disorder—Cisplatin—germ cell cancer	0.000427	0.00994	CcSEcCtD
Nateglinide—Abdominal pain—Vinblastine—germ cell cancer	0.000426	0.00993	CcSEcCtD
Nateglinide—Palpitations—Ifosfamide—germ cell cancer	0.000422	0.00982	CcSEcCtD
Nateglinide—SLC15A2—testis—germ cell cancer	0.000419	0.00394	CbGeAlD
Nateglinide—PPARG—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000416	0.0469	CbGpPWpGaD
Nateglinide—Cough—Ifosfamide—germ cell cancer	0.000416	0.0097	CcSEcCtD
Nateglinide—ORM1—lymph node—germ cell cancer	0.000415	0.0039	CbGeAlD
Nateglinide—Malnutrition—Cisplatin—germ cell cancer	0.000411	0.00958	CcSEcCtD
Nateglinide—Erythema multiforme—Etoposide—germ cell cancer	0.000409	0.00953	CcSEcCtD
Nateglinide—PPARG—brain—germ cell cancer	0.000401	0.00377	CbGeAlD
Nateglinide—Hypersensitivity—Vinblastine—germ cell cancer	0.000397	0.00926	CcSEcCtD
Nateglinide—PTGS1—uterus—germ cell cancer	0.000394	0.00371	CbGeAlD
Nateglinide—Immune system disorder—Etoposide—germ cell cancer	0.000391	0.00911	CcSEcCtD
Nateglinide—CYP2D6—telencephalon—germ cell cancer	0.000391	0.00368	CbGeAlD
Nateglinide—PPARG—lymph node—germ cell cancer	0.000388	0.00365	CbGeAlD
Nateglinide—PTGS1—pituitary gland—germ cell cancer	0.000387	0.00364	CbGeAlD
Nateglinide—Asthenia—Vinblastine—germ cell cancer	0.000387	0.00902	CcSEcCtD
Nateglinide—SLC15A2—cerebellum—germ cell cancer	0.000387	0.00364	CbGeAlD
Nateglinide—Tremor—Cisplatin—germ cell cancer	0.000385	0.00898	CcSEcCtD
Nateglinide—ALB—brain—germ cell cancer	0.000377	0.00354	CbGeAlD
Nateglinide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000376	0.00877	CcSEcCtD
Nateglinide—Osteoarthritis—Methotrexate—germ cell cancer	0.000375	0.00873	CcSEcCtD
Nateglinide—Diarrhoea—Vinblastine—germ cell cancer	0.000369	0.0086	CcSEcCtD
Nateglinide—Fatigue—Dactinomycin—germ cell cancer	0.000366	0.00853	CcSEcCtD
Nateglinide—ABCC4—brain—germ cell cancer	0.000365	0.00343	CbGeAlD
Nateglinide—Back pain—Etoposide—germ cell cancer	0.000364	0.00849	CcSEcCtD
Nateglinide—ALB—lymph node—germ cell cancer	0.000364	0.00342	CbGeAlD
Nateglinide—Urticaria—Bleomycin—germ cell cancer	0.000362	0.00843	CcSEcCtD
Nateglinide—CYP3A5—female gonad—germ cell cancer	0.000359	0.00338	CbGeAlD
Nateglinide—Dizziness—Vinblastine—germ cell cancer	0.000357	0.00831	CcSEcCtD
Nateglinide—ABCC4—lymph node—germ cell cancer	0.000352	0.00331	CbGeAlD
Nateglinide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000347	0.00809	CcSEcCtD
Nateglinide—PTGS1—adrenal gland—germ cell cancer	0.000346	0.00325	CbGeAlD
Nateglinide—Vomiting—Vinblastine—germ cell cancer	0.000343	0.00799	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000336	0.00783	CcSEcCtD
Nateglinide—Abdominal pain—Dactinomycin—germ cell cancer	0.000336	0.00782	CcSEcCtD
Nateglinide—Fatigue—Ifosfamide—germ cell cancer	0.000336	0.00782	CcSEcCtD
Nateglinide—Hypersensitivity—Bleomycin—germ cell cancer	0.000336	0.00782	CcSEcCtD
Nateglinide—CYP3A5—endocrine gland—germ cell cancer	0.000334	0.00314	CbGeAlD
Nateglinide—PTGS1—spinal cord—germ cell cancer	0.000333	0.00313	CbGeAlD
Nateglinide—Cough—Etoposide—germ cell cancer	0.000329	0.00766	CcSEcCtD
Nateglinide—CYP2C9—endocrine gland—germ cell cancer	0.000329	0.00309	CbGeAlD
Nateglinide—Asthenia—Bleomycin—germ cell cancer	0.000327	0.00761	CcSEcCtD
Nateglinide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000324	0.00756	CcSEcCtD
Nateglinide—PTGS1—female gonad—germ cell cancer	0.000323	0.00303	CbGeAlD
Nateglinide—Pruritus—Bleomycin—germ cell cancer	0.000322	0.00751	CcSEcCtD
Nateglinide—Nausea—Vinblastine—germ cell cancer	0.00032	0.00746	CcSEcCtD
Nateglinide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000318	0.00742	CcSEcCtD
Nateglinide—SLC15A2—brain—germ cell cancer	0.000314	0.00296	CbGeAlD
Nateglinide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000313	0.00729	CcSEcCtD
Nateglinide—Urticaria—Ifosfamide—germ cell cancer	0.000309	0.00721	CcSEcCtD
Nateglinide—Abdominal pain—Ifosfamide—germ cell cancer	0.000308	0.00717	CcSEcCtD
Nateglinide—Asthenia—Dactinomycin—germ cell cancer	0.000305	0.0071	CcSEcCtD
Nateglinide—SLC15A2—lymph node—germ cell cancer	0.000304	0.00286	CbGeAlD
Nateglinide—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000301	0.00701	CcSEcCtD
Nateglinide—PTGS1—endocrine gland—germ cell cancer	0.0003	0.00282	CbGeAlD
Nateglinide—Hyperhidrosis—Etoposide—germ cell cancer	0.000297	0.00692	CcSEcCtD
Nateglinide—PTGS1—head—germ cell cancer	0.000296	0.00278	CbGeAlD
Nateglinide—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.000292	0.0329	CbGpPWpGaD
Nateglinide—Diarrhoea—Dactinomycin—germ cell cancer	0.000291	0.00677	CcSEcCtD
Nateglinide—UGT1A9—Metapathway biotransformation—NAT9—germ cell cancer	0.000291	0.0328	CbGpPWpGaD
Nateglinide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00029	0.00675	CcSEcCtD
Nateglinide—Vomiting—Bleomycin—germ cell cancer	0.00029	0.00675	CcSEcCtD
Nateglinide—Rash—Bleomycin—germ cell cancer	0.000287	0.00669	CcSEcCtD
Nateglinide—Dermatitis—Bleomycin—germ cell cancer	0.000287	0.00669	CcSEcCtD
Nateglinide—Hypersensitivity—Ifosfamide—germ cell cancer	0.000287	0.00668	CcSEcCtD
Nateglinide—PTGS1—testis—germ cell cancer	0.000286	0.00269	CbGeAlD
Nateglinide—Asthenia—Ifosfamide—germ cell cancer	0.000279	0.00651	CcSEcCtD
Nateglinide—Sweating—Methotrexate—germ cell cancer	0.000277	0.00645	CcSEcCtD
Nateglinide—Pruritus—Ifosfamide—germ cell cancer	0.000275	0.00642	CcSEcCtD
Nateglinide—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000273	0.00636	CcSEcCtD
Nateglinide—Nausea—Bleomycin—germ cell cancer	0.000271	0.0063	CcSEcCtD
Nateglinide—Vomiting—Dactinomycin—germ cell cancer	0.00027	0.00629	CcSEcCtD
Nateglinide—Rash—Dactinomycin—germ cell cancer	0.000268	0.00624	CcSEcCtD
Nateglinide—Diarrhoea—Ifosfamide—germ cell cancer	0.000266	0.00621	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000265	0.00618	CcSEcCtD
Nateglinide—CYP2D6—female gonad—germ cell cancer	0.000265	0.00249	CbGeAlD
Nateglinide—Fatigue—Etoposide—germ cell cancer	0.000265	0.00618	CcSEcCtD
Nateglinide—Dizziness—Ifosfamide—germ cell cancer	0.000257	0.006	CcSEcCtD
Nateglinide—Nausea—Dactinomycin—germ cell cancer	0.000252	0.00588	CcSEcCtD
Nateglinide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000251	0.00586	CcSEcCtD
Nateglinide—CYP3A4—endocrine gland—germ cell cancer	0.000251	0.00236	CbGeAlD
Nateglinide—Vomiting—Ifosfamide—germ cell cancer	0.000248	0.00577	CcSEcCtD
Nateglinide—Hypersensitivity—Cisplatin—germ cell cancer	0.000247	0.00576	CcSEcCtD
Nateglinide—CYP2D6—endocrine gland—germ cell cancer	0.000247	0.00232	CbGeAlD
Nateglinide—Rash—Ifosfamide—germ cell cancer	0.000245	0.00572	CcSEcCtD
Nateglinide—Dermatitis—Ifosfamide—germ cell cancer	0.000245	0.00571	CcSEcCtD
Nateglinide—Erythema multiforme—Methotrexate—germ cell cancer	0.000245	0.00571	CcSEcCtD
Nateglinide—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.000244	0.0276	CbGpPWpGaD
Nateglinide—Urticaria—Etoposide—germ cell cancer	0.000244	0.00569	CcSEcCtD
Nateglinide—CYP2D6—head—germ cell cancer	0.000243	0.00229	CbGeAlD
Nateglinide—Abdominal pain—Etoposide—germ cell cancer	0.000243	0.00566	CcSEcCtD
Nateglinide—Asthenia—Cisplatin—germ cell cancer	0.000241	0.00561	CcSEcCtD
Nateglinide—CYP2D6—testis—germ cell cancer	0.000235	0.00221	CbGeAlD
Nateglinide—Immune system disorder—Methotrexate—germ cell cancer	0.000234	0.00546	CcSEcCtD
Nateglinide—Nausea—Ifosfamide—germ cell cancer	0.000231	0.00539	CcSEcCtD
Nateglinide—Diarrhoea—Cisplatin—germ cell cancer	0.00023	0.00535	CcSEcCtD
Nateglinide—Hypersensitivity—Etoposide—germ cell cancer	0.000227	0.00528	CcSEcCtD
Nateglinide—Malnutrition—Methotrexate—germ cell cancer	0.000226	0.00526	CcSEcCtD
Nateglinide—Asthenia—Etoposide—germ cell cancer	0.000221	0.00514	CcSEcCtD
Nateglinide—Back pain—Methotrexate—germ cell cancer	0.000218	0.00509	CcSEcCtD
Nateglinide—Pruritus—Etoposide—germ cell cancer	0.000218	0.00507	CcSEcCtD
Nateglinide—CYP2D6—cerebellum—germ cell cancer	0.000217	0.00204	CbGeAlD
Nateglinide—PTGS1—brain—germ cell cancer	0.000215	0.00202	CbGeAlD
Nateglinide—Vomiting—Cisplatin—germ cell cancer	0.000213	0.00497	CcSEcCtD
Nateglinide—Rash—Cisplatin—germ cell cancer	0.000212	0.00493	CcSEcCtD
Nateglinide—Dermatitis—Cisplatin—germ cell cancer	0.000211	0.00493	CcSEcCtD
Nateglinide—Diarrhoea—Etoposide—germ cell cancer	0.00021	0.0049	CcSEcCtD
Nateglinide—PTGS1—lymph node—germ cell cancer	0.000207	0.00195	CbGeAlD
Nateglinide—Dizziness—Etoposide—germ cell cancer	0.000203	0.00474	CcSEcCtD
Nateglinide—Nausea—Cisplatin—germ cell cancer	0.000199	0.00464	CcSEcCtD
Nateglinide—Cough—Methotrexate—germ cell cancer	0.000197	0.00459	CcSEcCtD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—KLF4—germ cell cancer	0.000197	0.0222	CbGpPWpGaD
Nateglinide—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000196	0.0221	CbGpPWpGaD
Nateglinide—Vomiting—Etoposide—germ cell cancer	0.000196	0.00455	CcSEcCtD
Nateglinide—Rash—Etoposide—germ cell cancer	0.000194	0.00452	CcSEcCtD
Nateglinide—Dermatitis—Etoposide—germ cell cancer	0.000194	0.00451	CcSEcCtD
Nateglinide—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000194	0.0218	CbGpPWpGaD
Nateglinide—Nausea—Etoposide—germ cell cancer	0.000183	0.00425	CcSEcCtD
Nateglinide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000178	0.00415	CcSEcCtD
Nateglinide—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000177	0.0199	CbGpPWpGaD
Nateglinide—CYP2D6—brain—germ cell cancer	0.000176	0.00166	CbGeAlD
Nateglinide—ALB—Transport of organic anions—AVP—germ cell cancer	0.000174	0.0197	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—CD9—germ cell cancer	0.000166	0.0187	CbGpPWpGaD
Nateglinide—Dyspepsia—Methotrexate—germ cell cancer	0.000162	0.00378	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000159	0.0037	CcSEcCtD
Nateglinide—Fatigue—Methotrexate—germ cell cancer	0.000159	0.0037	CcSEcCtD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000158	0.0178	CbGpPWpGaD
Nateglinide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000151	0.00351	CcSEcCtD
Nateglinide—Urticaria—Methotrexate—germ cell cancer	0.000146	0.00341	CcSEcCtD
Nateglinide—Abdominal pain—Methotrexate—germ cell cancer	0.000146	0.00339	CcSEcCtD
Nateglinide—Hypersensitivity—Methotrexate—germ cell cancer	0.000136	0.00316	CcSEcCtD
Nateglinide—Asthenia—Methotrexate—germ cell cancer	0.000132	0.00308	CcSEcCtD
Nateglinide—Pruritus—Methotrexate—germ cell cancer	0.00013	0.00304	CcSEcCtD
Nateglinide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000128	0.0144	CbGpPWpGaD
Nateglinide—Diarrhoea—Methotrexate—germ cell cancer	0.000126	0.00294	CcSEcCtD
Nateglinide—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000126	0.0142	CbGpPWpGaD
Nateglinide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000126	0.0142	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000125	0.014	CbGpPWpGaD
Nateglinide—Dizziness—Methotrexate—germ cell cancer	0.000122	0.00284	CcSEcCtD
Nateglinide—Vomiting—Methotrexate—germ cell cancer	0.000117	0.00273	CcSEcCtD
Nateglinide—Rash—Methotrexate—germ cell cancer	0.000116	0.00271	CcSEcCtD
Nateglinide—Dermatitis—Methotrexate—germ cell cancer	0.000116	0.0027	CcSEcCtD
Nateglinide—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000113	0.0128	CbGpPWpGaD
Nateglinide—Nausea—Methotrexate—germ cell cancer	0.000109	0.00255	CcSEcCtD
Nateglinide—ABCC4—NRF2 pathway—SLC2A3—germ cell cancer	0.000106	0.0119	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—SLC2A3—germ cell cancer	9.13e-05	0.0103	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.93e-05	0.0101	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	8.79e-05	0.00991	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—SOX2—germ cell cancer	8.65e-05	0.00974	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.41e-05	0.00948	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	8.28e-05	0.00934	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	8.22e-05	0.00926	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	7.81e-05	0.0088	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	7.69e-05	0.00867	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—CD9—germ cell cancer	7.51e-05	0.00846	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—CD9—germ cell cancer	7.36e-05	0.00829	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.26e-05	0.00818	CbGpPWpGaD
Nateglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	7.21e-05	0.00813	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TDGF1—germ cell cancer	7.2e-05	0.00812	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NR0B1—germ cell cancer	7.19e-05	0.00811	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	7.15e-05	0.00806	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.93e-05	0.00782	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.53e-05	0.00736	CbGpPWpGaD
Nateglinide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	6.47e-05	0.00729	CbGpPWpGaD
Nateglinide—UGT1A9—PPAR Alpha Pathway—MYC—germ cell cancer	6.43e-05	0.00725	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	6.2e-05	0.00699	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—SALL4—germ cell cancer	6.12e-05	0.0069	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.06e-05	0.00683	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NANOG—germ cell cancer	5.87e-05	0.00662	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	5.79e-05	0.00653	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	5.71e-05	0.00643	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—POU5F1—germ cell cancer	5.65e-05	0.00637	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.17e-05	0.00583	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—CD9—germ cell cancer	5.09e-05	0.00573	CbGpPWpGaD
Nateglinide—ABCC4—Fluoropyrimidine Activity—TP53—germ cell cancer	5.05e-05	0.00569	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.75e-05	0.00535	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.68e-05	0.00527	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.54e-05	0.00511	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.5e-05	0.00507	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.47e-05	0.00504	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KLF4—germ cell cancer	4.45e-05	0.00501	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—MYC—germ cell cancer	4.3e-05	0.00484	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.27e-05	0.00482	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.21e-05	0.00475	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.12e-05	0.00464	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.97e-05	0.00447	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.91e-05	0.0044	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.88e-05	0.00437	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—AVP—germ cell cancer	3.79e-05	0.00428	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—CD9—germ cell cancer	3.79e-05	0.00428	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.6e-05	0.00406	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NR0B1—germ cell cancer	3.46e-05	0.0039	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.38e-05	0.00381	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.33e-05	0.00376	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	3.33e-05	0.00375	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—SOX2—germ cell cancer	3.13e-05	0.00353	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	3.01e-05	0.00339	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—DNMT3L—germ cell cancer	3e-05	0.00338	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	2.97e-05	0.00334	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.94e-05	0.00332	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.9e-05	0.00327	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.87e-05	0.00324	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—RARS—germ cell cancer	2.79e-05	0.00315	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	2.69e-05	0.00303	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	2.67e-05	0.00301	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.47e-05	0.00278	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.34e-05	0.00264	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—SLC2A3—germ cell cancer	2.22e-05	0.00251	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—SLC22A3—germ cell cancer	2.19e-05	0.00247	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—AVP—germ cell cancer	2.19e-05	0.00247	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—SLC2A3—germ cell cancer	2.16e-05	0.00243	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—SLC2A3—germ cell cancer	2.12e-05	0.00239	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—SLC22A3—germ cell cancer	2.12e-05	0.00239	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—SLC22A3—germ cell cancer	2.09e-05	0.00236	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.09e-05	0.00236	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.01e-05	0.00227	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.97e-05	0.00222	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—MYC—germ cell cancer	1.96e-05	0.00221	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.83e-05	0.00206	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CRABP1—germ cell cancer	1.79e-05	0.00201	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CRABP1—germ cell cancer	1.73e-05	0.00195	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—CD9—germ cell cancer	1.72e-05	0.00193	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CRABP1—germ cell cancer	1.71e-05	0.00192	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SLC2A3—germ cell cancer	1.59e-05	0.0018	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SLC22A3—germ cell cancer	1.57e-05	0.00177	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—AVP—germ cell cancer	1.56e-05	0.00176	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.53e-05	0.00173	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.51e-05	0.0017	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	1.39e-05	0.00157	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SLC2A3—germ cell cancer	1.37e-05	0.00154	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	1.36e-05	0.00153	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SLC22A3—germ cell cancer	1.35e-05	0.00152	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—germ cell cancer	1.31e-05	0.00148	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.29e-05	0.00146	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CRABP1—germ cell cancer	1.28e-05	0.00144	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—HRAS—germ cell cancer	1.23e-05	0.00138	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—germ cell cancer	1.2e-05	0.00135	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—HRAS—germ cell cancer	1.19e-05	0.00134	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.15e-05	0.0013	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.13e-05	0.00128	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC2A3—germ cell cancer	1.12e-05	0.00126	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC22A3—germ cell cancer	1.1e-05	0.00124	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CRABP1—germ cell cancer	1.1e-05	0.00124	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.06e-05	0.00119	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—H2AFZ—germ cell cancer	1.05e-05	0.00118	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CRABP1—germ cell cancer	9.25e-06	0.00104	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CRABP1—germ cell cancer	8.96e-06	0.00101	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC2A3—germ cell cancer	8.32e-06	0.000938	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC22A3—germ cell cancer	8.2e-06	0.000924	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—germ cell cancer	7.62e-06	0.000859	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—germ cell cancer	7.54e-06	0.00085	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—germ cell cancer	7.29e-06	0.000822	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC2A3—germ cell cancer	7.17e-06	0.000808	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC22A3—germ cell cancer	7.06e-06	0.000796	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	7.06e-06	0.000796	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CRABP1—germ cell cancer	6.68e-06	0.000753	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A3—germ cell cancer	5.92e-06	0.000667	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A3—germ cell cancer	5.87e-06	0.000661	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC22A3—germ cell cancer	5.83e-06	0.000657	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC22A3—germ cell cancer	5.78e-06	0.000651	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CRABP1—germ cell cancer	5.76e-06	0.000649	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—germ cell cancer	5.68e-06	0.000641	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—germ cell cancer	5.57e-06	0.000628	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—germ cell cancer	5.44e-06	0.000613	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CRABP1—germ cell cancer	4.75e-06	0.000536	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CRABP1—germ cell cancer	4.71e-06	0.000531	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.87e-06	0.000436	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.81e-06	0.00043	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—germ cell cancer	3.63e-06	0.000409	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.11e-06	0.00035	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—germ cell cancer	2.57e-06	0.00029	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—germ cell cancer	2.46e-06	0.000277	CbGpPWpGaD
